PRVB
Closed
Provention Bio Inc
24.98
+0.75 (+3.10%)
Last Update: 27 Apr 2023 16:30:00
Yesterday: 24.23
Day's Range: 24.98 - 24.98
Send
sign up or login to leave a comment!
When Written:
24.44
Provention Bio Inc. is a clinical-stage biopharmaceutical company that focuses on developing and commercializing therapies for autoimmune and inflammatory diseases, including type 1 diabetes, celiac disease, and lupus. The company's lead product candidate, teplizumab, is currently in Phase 3 clinical trials for the prevention or delay of type 1 diabetes. Provention Bio also has a pipeline of other potential therapies in various stages of development. The company was founded in 2016 and is headquartered in Oldwick, New Jersey.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








